GH Research PLC (GHRS)
NASDAQ: GHRS · Real-Time Price · USD
9.10
+0.40 (4.60%)
Apr 17, 2025, 4:00 PM EDT - Market closed
GH Research Market Cap
GH Research has a market cap or net worth of $564.46 million as of April 17, 2025. Its market cap has decreased by -1.28% in one year.
Market Cap
564.46M
Enterprise Value
382.46M
1-Year Change
-1.28%
Ranking
Category
Stock Price
$9.10
Market Cap Chart
Since the IPO on June 25, 2021, GH Research's market cap has decreased from $808.33M to $564.46M, a decrease of -30.17%. That is a compound annual growth rate of -8.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 17, 2025 | 564.46M | 54.99% |
| Dec 31, 2024 | 364.20M | 20.71% |
| Dec 29, 2023 | 301.72M | -40.33% |
| Dec 30, 2022 | 505.64M | -58.34% |
| Dec 31, 2021 | 1.21B | 50.14% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 679.94B |
| UnitedHealth Group | 533.82B |
| Johnson & Johnson | 370.25B |
| AbbVie | 312.76B |
| Novo Nordisk | 286.28B |
| Abbott Laboratories | 218.91B |
| AstraZeneca | 210.97B |
| Novartis AG | 209.02B |